Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and ...
LOS ANGELES -- For people trying to quit smoking, use of a GLP-1 receptor agonist may help prevent weight gain, a common barrier to quitting, researchers said here. In a systematic review and ...
LOS ANGELES — Treating nicotine addiction with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) was associated with less weight gain compared with other smoking cessation treatments such as ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The systematic review and meta-analysis included three ...
Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications. GLP-1 RAs are not recommended during pregnancy due to potential ...
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and ...
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results